Wendell David Associates Inc Novo Nordisk A S Transaction History

Wendell David Associates Inc

  • $1.05 Billion
  • Q3 2024

A detailed history of Wendell David Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wendell David Associates Inc holds 76,622 shares of NVO stock, worth $6.8 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
76,622
Previous 77,122 0.65%
Holding current value
$6.8 Million
Previous $11 Million 17.12%
% of portfolio
0.87%
Previous 1.12%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$119.07 - $145.42 $59,535 - $72,710
-500 Reduced 0.65%
76,622 $9.12 Million
Q2 2024

Jul 22, 2024
SELL
$122.71 - $146.91 $12,271 - $14,691
-100 Reduced 0.13%
77,122 $11 Million
Q1 2024

Apr 22, 2024
SELL
$102.11 - $135.92 $25,323 - $33,708
-248 Reduced 0.32%
77,222 $9.92 Million
Q4 2023

Jan 22, 2024
BUY
$87.78 - $105.45 $614,460 - $738,150
7,000 Added 9.93%
77,470 $8.01 Million
Q3 2023

Oct 20, 2023
BUY
$90.94 - $199.54 $3.21 Million - $7.05 Million
35,335 Added 100.57%
70,470 $6.41 Million
Q2 2023

Jul 20, 2023
SELL
$155.98 - $172.65 $88,752 - $98,237
-569 Reduced 1.59%
35,135 $5.69 Million
Q1 2023

Apr 19, 2023
SELL
$132.34 - $159.14 $266,665 - $320,667
-2,015 Reduced 5.34%
35,704 $5.68 Million
Q2 2022

Jul 14, 2022
SELL
$103.24 - $121.81 $36,030 - $42,511
-349 Reduced 0.92%
37,719 $4.2 Million
Q1 2022

Apr 22, 2022
SELL
$93.1 - $112.54 $353,780 - $427,652
-3,800 Reduced 9.08%
38,068 $4.23 Million
Q4 2021

Jan 24, 2022
BUY
$95.88 - $117.08 $4,698 - $5,736
49 Added 0.12%
41,868 $4.69 Million
Q3 2021

Oct 19, 2021
BUY
$84.42 - $106.62 $39,592 - $50,004
469 Added 1.13%
41,819 $4.02 Million
Q2 2021

Jul 19, 2021
SELL
$67.66 - $84.76 $71,043 - $88,998
-1,050 Reduced 2.48%
41,350 $3.46 Million
Q3 2020

Oct 20, 2020
SELL
$63.69 - $70.22 $55,728 - $61,442
-875 Reduced 2.02%
42,400 $2.94 Million
Q2 2020

Jul 17, 2020
SELL
$58.54 - $67.94 $23,416 - $27,176
-400 Reduced 0.92%
43,275 $2.83 Million
Q3 2019

Oct 22, 2019
SELL
$47.54 - $53.43 $172,332 - $193,683
-3,625 Reduced 7.66%
43,675 $2.26 Million
Q2 2019

Jul 16, 2019
SELL
$46.79 - $52.47 $10,527 - $11,805
-225 Reduced 0.47%
47,300 $2.41 Million
Q4 2018

Jan 17, 2019
SELL
$41.54 - $47.25 $44,364 - $50,463
-1,068 Reduced 2.2%
47,525 $2.19 Million
Q3 2018

Oct 12, 2018
SELL
$46.76 - $51.24 $51,436 - $56,364
-1,100 Reduced 2.21%
48,593 $2.29 Million
Q1 2018

Apr 11, 2018
SELL
$48.49 - $58.14 $67,886 - $81,396
-1,400 Reduced 2.74%
49,693 $2.45 Million
Q4 2017

Jan 16, 2018
SELL
$47.53 - $53.73 $65,021 - $73,502
-1,368 Reduced 2.61%
51,093 $2.74 Million
Q3 2017

Oct 17, 2017
BUY
$41.15 - $49.22 $2.16 Million - $2.58 Million
52,461
52,461 $2.53 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email